Hui‐Hua Li
Impact in
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
-
- Cardiac Fibrosis and Remodeling
- Cardiac Valve Diseases and Treatments
Papers in
-
- Cardiac Fibrosis and Remodeling 41
- Renin-Angiotensin System Studies 15
- Atrial Fibrillation Management and Outcomes 10
- Immunology 36
- Atherosclerosis and Cardiovascular Diseases 11
- Journals
- PLoS ONE (9 papers)Cellular Physiology and Biochemistry (8 papers)Redox Biology (7 papers)Scientific Reports (6 papers)Hypertension (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hui‐Hua Li
219 papers receiving 7.6k citations
Peers
Comparison fields: 5 of 149
- Transplantation 367
- Cardiology and Cardiovascular Medicine 2.3k
- Immunology 1.1k
- Cancer Research 713
- Molecular Biology 3.3k
Countries citing papers authored by Hui‐Hua Li
This map shows the geographic impact of Hui‐Hua Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Hua Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Hua Li more than expected).
Fields of papers citing papers by Hui‐Hua Li
This network shows the impact of papers produced by Hui‐Hua Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Hua Li. The network helps show where Hui‐Hua Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui‐Hua Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 27 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 9 | |
| 8 | 2019 | 19 | |
| 9 | 2019 | 28 | |
| 10 | 2019 | 8 | |
| 11 | 2018 | 23 | |
| 12 | 2018 | 124 | |
| 13 | 2018 | 26 | |
| 14 | 2018 | 17 | |
| 15 | 2018 | 46 | |
| 16 | 2016 | 27 | |
| 17 | 2015 | 31 | |
| 18 | 2010 | 1 | |
| 19 | 2009 | 87 | |
| 20 | 2004 | 309 |
About Hui‐Hua Li
Hui‐Hua Li is a scholar working on Cardiology and Cardiovascular Medicine, Immunology, Molecular Biology, Neurology and Cancer Research, having authored 225 papers that have together received 7.7k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (41 papers), Signaling Pathways in Disease (26 papers), Peptidase Inhibition and Analysis (21 papers), Ubiquitin and proteasome pathways (21 papers), Cardiac Ischemia and Reperfusion (16 papers), Renin-Angiotensin System Studies (15 papers), Atherosclerosis and Cardiovascular Diseases (11 papers) and Atrial Fibrillation Management and Outcomes (10 papers). The work is most often cited by research in Transplantation (367 citations), Cardiology and Cardiovascular Medicine (2.3k citations), Immunology (1.1k citations), Cancer Research (713 citations) and Molecular Biology (3.3k citations). Hui‐Hua Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jie Du, Yulin Li, Yun‐Long Zhang, Lixin Jia, Qiu‐Yue Lin, Cui Tian, Hongxia Wang, Yunlong Xia, Gary L. Grunkemeier and Jie Bai. Their work appears in journals such as PLoS ONE, Cellular Physiology and Biochemistry, Redox Biology, Scientific Reports and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.